PhRMA revived its push to add an FDA bug linking to risk info in search engine sponsored links and called on FDA to clear the way for "microblogging of newsworthy regulatory events" on drugs and biologics.

What began as a sparkly new ad for perfume quickly shifted gears, from trivial to terrifying, once the young female actor glimpsed the perfume bottle's script: cervical cancer.

Doctors that demonstrate the "meaningful use" of electronic health records (EHR) in their practices are eligible for at least $44,000 over five years, an incentive the American Medical Association is facilitating with a new partnership.

About 80% of all US physicians will be using smart phones by 2012, and not just for drug reference or clinical information. An explosion of new healthcare professional-facing apps - over 1,500 in Apple's app store alone - will expand mobile device usage to include patient care and administrative functions, according to Manhattan Research survey.

Pharma spending on consumer advertising was largely flat in 2009, rising 1.9% to $4.5 billion over 2008 spend, according to data from The Nielsen Company. That's good news for media companies, suggesting that spending has hit bottom following two years of steep declines.

Sanofi-Aventis is poised to launch a new Xyzal campaign for allergy season, having recently acquired full commercialization responsibilities on the drug after UCB's exit from US primary care in February.

It's not exactly news that Razorfish has a health practice, but the digital agency, which was acquired by Publicis last year, is making it official with the launch of Razorfish Health, an "independent, dedicated" health and wellness agency.

A federal appeals court will hear oral arguments regarding Maine's prescription data law, which allows physicians to "opt-out" of commercially traded data pertaining to their prescribing habits.

DDMAC is being upgraded from a division to an office, an FDA official said yesterday.

Eisai got an FDA untitled letter for two Aricept TV ads that the agency said overstate the efficacy of the drug.